|
KMID : 0620920200520030020
|
|
Experimental & Molecular Medicine
2020 Volume.52 No. 3 p.20 ~ p.20
|
|
|
The dynactin subunit DCTN1 controls osteoclastogenesis via the Cdc42/PAK2 pathway
|
|
Lee Yong-Deok
Kim Bong-Jun
Jung Su-Han
Kim Hae-Min
Kim Min-Kyung
Kwon Jun-Oh
Song Min-Kyoung
Lee Zang-Hee
Kim Hong-Hee
|
|
|
Abstract
|
|
|
|
Osteoclasts (OCs), cells specialized for bone resorption, are generated from monocyte/macrophage precursors by a differentiation process governed by RANKL. Here, we show that DCTN1, a key component of the dynactin complex, plays important roles in OC differentiation. The expression of DCTN1 was upregulated by RANKL. The inhibition of DCTN1 expression by gene knockdown suppressed OC formation, bone resorption, and the induction of NFATc1 and c-Fos, critical transcription factors for osteoclastogenesis. More importantly, the activation of Cdc42 by RANKL was inhibited upon DCTN1 silencing. The forced expression of constitutively active Cdc42 restored the OC differentiation of precursors with DCTN1 deletion. In addition, PAK2 was found to be activated by RANKL and to function downstream of Cdc42. The DCTN1-Cdc42 axis also inhibited apoptosis and caspase-3 activation. Furthermore, the anti-osteoclastogenic effect of DCTN1 knockdown was verified in an animal model of bone erosion. Intriguingly, DCTN1 overexpression was also detrimental to OC differentiation, suggesting that DCTN1 should be regulated at the appropriate level for effective osteoclastogenesis. Collectively, our results reveal that DCTN1 participates in the activation of Cdc42/PAK2 signaling and the inhibition of apoptosis during osteoclastogenesis.
|
|
|
KEYWORD
|
|
|
Experimental models of disease, Mechanisms of disease
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|
|